Immunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax(TM) Platform

Corporate Breaking News

Home : Immunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax(TM) Platform

Aug 02 2013	Immunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax(TM) Platform
Support from Province of Nova Scotia Offers Validation of IMV Clinical Programs; Ensures Funding Available for Additional Clinical Development in Coming Years


Source:http://www.marketwire.com/mw/release.do?id=1817303&sourceType=3

Related News
» Gold Canyon Arranges $1,954,440 Non-brokered Private Placement » Paladin Energy Ltd Announces Successful Institutional Placement of Shares to Raise A$88M / C$81M